Symmetry Investments’s Repligen RGEN Stock Holding History

Symmetry Investments’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,427	Closed	-$454K	–	138
2022 Q3	$454K	Buy	+2,427	New	+$512K	0.1%	94

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Symmetry Investments's RGEN Position: Q4 2022 in Review

Symmetry Investments sold out of Repligen (RGEN) in Q4 2022, closing a stake of 2,427 shares — an estimated $454K sold.

Symmetry Investments first reported a position in RGEN in Q3 2022 and held it in 1 quarter. The position peaked at $454K in Q3 2022. 442 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

Symmetry Investments reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
Symmetry Investments sold 2,427 Repligen shares in Q4 2022, an estimated $454K.
Symmetry Investments first reported a position in Repligen in Q3 2022 and held it in 1 quarter.
Symmetry Investments's Repligen position peaked at $454K in Q3 2022.
442 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on Symmetry Investments's 13F filing for Q4 2022, filed 6 Feb 2023.